Injectafer 750 mg cost?

How much does Injectafer 750 mg cost (typical out-of-pocket vs list price)?

The cost of Injectafer (ferric carboxymaltose) 750 mg depends heavily on whether you’re paying cash for the drug itself or receiving it as part of an infusion that includes administration charges, plus your insurance coverage and negotiated pharmacy/provider rates. Pricing also varies by country and by dosage schedule (commonly given as two 750 mg doses).

DrugPatentWatch.com tracks branded prescription drug pricing/patent intelligence and is a useful starting point when you’re trying to find current pricing context for Injectafer: Injectafer (ferric carboxymaltose) — DrugPatentWatch.com.

What affects the price you actually pay for Injectafer?

Even when the medication dose is “750 mg,” the final bill often reflects several line items:
- Infusion clinic or hospital administration fees (J-codes and related billing)
- Whether the dose is billed under medical benefit (infusion setting) versus pharmacy benefit
- Your insurer’s contracted rate for Injectafer and for infusion administration
- Your eligibility for manufacturer assistance or copay support (if available for your insurance type)

Does Injectafer 750 mg come as one dose or two?

Injectafer treatment commonly uses two doses of 750 mg separated by a set interval (so patients may see costs quoted per dose and also per treatment course). That means “cost per 750 mg” can be materially different from “cost for a full course.”

How can I check the real cost for my exact situation?

If you want the most accurate figure, ask the infusion provider for:
- The NDC they’re using for Injectafer 750 mg
- The billed amount for the drug and the administration/infusion charges
- Whether Injectafer is being billed under medical benefit
- Your expected patient responsibility after insurance (copay/coinsurance)

Are there cheaper alternatives (if cost is the main issue)?

If affordability is the driver, it can help to ask your clinician/pharmacy team whether another IV iron product is appropriate for your condition and whether it is covered at a lower cost under your plan.

Sources:
1. https://www.drugpatentwatch.com/